Cargando…

Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects

Ventricular septal defects (VSDs) are the most common kind of congenital heart disease and, if indicated, surgical closure has been accepted as a gold-standard treatment. However, as less-invasive methods are preferred, percutaneous device closure has been developed. After the first VSD closure was...

Descripción completa

Detalles Bibliográficos
Autor principal: Song, Jinyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011220/
https://www.ncbi.nlm.nih.gov/pubmed/36914603
http://dx.doi.org/10.4070/kcj.2022.0336
_version_ 1784906342328172544
author Song, Jinyoung
author_facet Song, Jinyoung
author_sort Song, Jinyoung
collection PubMed
description Ventricular septal defects (VSDs) are the most common kind of congenital heart disease and, if indicated, surgical closure has been accepted as a gold-standard treatment. However, as less-invasive methods are preferred, percutaneous device closure has been developed. After the first VSD closure was performed percutaneously by Lock in 1988, both techniques and devices have developed consistently. A perventricular approach for closure of muscular VSD in small patients and the closure of perimembranous VSD using off-label devices are key remarkable developments. Even though the Amplatzer membranous VSD occluder (Abbott) could not be approved for use due to the high complete atrioventricular conduction block rate, other new devices have shown good results for closure of perimembranous VSDs. However, the transcatheter technique is slightly complicated to perform, and concerns about conduction problems after VSD closure with devices remain. There have been a few reports demonstrating successful closure of subarterial-type VSDs with Amplatzer devices, but long-term issues involving aortic valve damage have not been explored yet. In conclusion, transcatheter VSD closure should be accepted as being as effective and safe as surgery but should only be performed by experienced persons and in specialized institutes because the procedure is complex and requires different techniques. To avoid serious complications, identifying appropriate patient candidates for device closure before the procedure is very important.
format Online
Article
Text
id pubmed-10011220
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-100112202023-03-15 Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects Song, Jinyoung Korean Circ J State of the Art Review Ventricular septal defects (VSDs) are the most common kind of congenital heart disease and, if indicated, surgical closure has been accepted as a gold-standard treatment. However, as less-invasive methods are preferred, percutaneous device closure has been developed. After the first VSD closure was performed percutaneously by Lock in 1988, both techniques and devices have developed consistently. A perventricular approach for closure of muscular VSD in small patients and the closure of perimembranous VSD using off-label devices are key remarkable developments. Even though the Amplatzer membranous VSD occluder (Abbott) could not be approved for use due to the high complete atrioventricular conduction block rate, other new devices have shown good results for closure of perimembranous VSDs. However, the transcatheter technique is slightly complicated to perform, and concerns about conduction problems after VSD closure with devices remain. There have been a few reports demonstrating successful closure of subarterial-type VSDs with Amplatzer devices, but long-term issues involving aortic valve damage have not been explored yet. In conclusion, transcatheter VSD closure should be accepted as being as effective and safe as surgery but should only be performed by experienced persons and in specialized institutes because the procedure is complex and requires different techniques. To avoid serious complications, identifying appropriate patient candidates for device closure before the procedure is very important. The Korean Society of Cardiology 2023-02-06 /pmc/articles/PMC10011220/ /pubmed/36914603 http://dx.doi.org/10.4070/kcj.2022.0336 Text en Copyright © 2023. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle State of the Art Review
Song, Jinyoung
Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
title Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
title_full Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
title_fullStr Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
title_full_unstemmed Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
title_short Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
title_sort percutaneous transcatheter closure of congenital ventricular septal defects
topic State of the Art Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011220/
https://www.ncbi.nlm.nih.gov/pubmed/36914603
http://dx.doi.org/10.4070/kcj.2022.0336
work_keys_str_mv AT songjinyoung percutaneoustranscatheterclosureofcongenitalventricularseptaldefects